# CoMentis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/comentis

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.comentis.com
- Total disclosed funding: $87M
- Latest round: Series E (Mar 2, 2016)
- Investors on record: 6

## About

Founded in 2004 and is based in South San Francisco, California. CoMentis, Inc. is  a biotech company, engages in the research, discovery, and development of small-molecule drugs to treat neurovascular diseases.

## Funding rounds

- Series E, Mar 2, 2016, $4.5M — Sanderling Ventures, Clarus Ventures
- Series D, Jun 5, 2008, $20M — Index Ventures, Sanderling Ventures, Astellas Venture Management, Clarus Ventures
- Series C, Oct 24, 2007, $12M — Sanderling Ventures, Wellington Partners
- Series B, Aug 23, 2007, $15M — Sanderling Ventures, Clarus Ventures
- Series B, Mar 1, 2007, $12M — Sanderling Ventures, Clarus Ventures
- Series B, Sep 21, 2006, $20M — Index Ventures, Sanderling Ventures, Charter Life Sciences, Astellas Venture Management, Clarus Ventures
- Series A, Feb 15, 2006, $3M — Sanderling Ventures, Charter Life Sciences

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series A, Series B, Series C, Series D, Series E
- Charter Life Sciences (https://capitalatlas.ai/funds/charter-life-sciences) — Series A, Series B
- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series B, Series D
- Astellas Venture Management (https://capitalatlas.ai/funds/astellas-venture-management) — Series B, Series D
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series B, Series D, Series E
- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series C